World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
134
Citations
83870
World Ranking
198
National Ranking
129

Molecular Biology

D-Index
126
Citations
75200
World Ranking
211
National Ranking
128

Peter D. Kwong publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Peter D. Kwong sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 780 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Peter D. Kwong D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Peter D. Kwong sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 134 D-Index — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Peter D. Kwong is affiliated with Columbia University in the United States. Their research focuses primarily on medicine, immunology and microbiology, and biochemistry, genetics and molecular biology.

The main subfields of study in which they are active include infectious diseases, molecular biology, virology, immunology, and epidemiology. Their work covers topics such as SARS-CoV-2 and COVID-19 research, HIV research and treatment, monoclonal and polyclonal antibodies research, viral gastroenteritis research and epidemiology, animal virus infections, vaccines and immunoinformatics approaches, and glycosylation and glycoproteins research.

Frequent co-authors in their publications are:

  • Tongqing Zhou
  • John R. Mascola
  • Baoshan Zhang
  • Adam S. Olia
  • I-Ting Teng

The scientist publishes regularly in several venues. The most frequent publication venues include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Cell Reports
  • Nature Communications
  • Science Translational Medicine
  • Vaccines

Representative recent papers include:

  • Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike, 2020, Nature
  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates, 2020, New England Journal of Medicine
  • Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization, 2021, Cell Host & Microbe
  • Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite, 2021, Cell Host & Microbe
  • LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants, 2022, Cell Reports

Best Publications

  • Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

    Peter D. Kwong;Richard Wyatt;James Robinson;Raymond W. Sweet

  • Antibody neutralization and escape by HIV-1

    Xiping Wei;Julie M. Decker;Shuyi Wang;Huxiong Hui

  • Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.

    Pengfei Wang;Manoj S. Nair;Lihong Liu;Sho Iketani;Sho Iketani

  • Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1

    Xueling Wu;Zhi Yong Yang;Yuxing Li;Carl Magnus Hogerkorp

  • The antigenic structure of the HIV gp120 envelope glycoprotein

    Richard Wyatt;Peter D. Kwong;Elizabeth Desjardins;Raymond W. Sweet

  • Structural basis of cell-cell adhesion by cadherins.

    Lawrence Shapiro;Allison M. Fannon;Peter D. Kwong;Andrew Thompson

  • Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike.

    Lihong Liu;Pengfei Wang;Manoj S. Nair;Jian Yu

  • Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01.

    Tongqing Zhou;Ivelin Georgiev;Xueling Wu;Zhi Yong Yang

  • A Conserved HIV gp120 Glycoprotein Structure Involved in Chemokine Receptor Binding

    Carlo D. Rizzuto;Richard Wyatt;Richard Wyatt;Nivia Hernández-Ramos;Nivia Hernández-Ramos;Ying Sun;Ying Sun

  • Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

    Hua-Xin Liao;Rebecca Lynch;Tongqing Zhou;Feng Gao;Feng Gao

  • HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites

    Peter D. Kwong;Peter D. Kwong;Michael L. Doyle;Michael L. Doyle;David J. Casper;Claudia Cicala

  • Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

    Jason S. McLellan;Man Chen;M. Gordon Joyce;Mallika Sastry

  • Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.

    Kizzmekia S Corbett;Barbara Flynn;Kathryn E Foulds;Joseph R Francica

  • HIV vaccine design and the neutralizing antibody problem

    Dennis R Burton;Ronald C Desrosiers;Robert W Doms;Wayne C Koff

  • Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9

    Jason S. McLellan;Marie Pancera;Chris Carrico;Jason Gorman

  • Broad and potent neutralization of HIV-1 by a gp41-specific human antibody

    Jinghe Huang;Gilad Ofek;Leo Laub;Mark K. Louder

  • Focused evolution of hiv-1 neutralizing antibodies revealed by crystal structures and deep sequencing

    John R. Mascola;Gary Nabel;Barton F. Haynes;Xueling Wu

  • Structural definition of a conserved neutralization epitope on HIV-1 gp120.

    Tongqing Zhou;Ling Xu;Barna Dey;Ann J. Hessell

  • Structure of a V3-Containing HIV-1 gp120 Core

    Chih-chin Huang;Min Tang;Mei-Yun Zhang;Shahzad Majeed

  • Structure of RSV Fusion Glycoprotein Trimer Bound to a Prefusion-Specific Neutralizing Antibody

    Jason S. McLellan;Man Chen;Sherman Leung;Kevin W. Graepel

  • Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization

    Pengfei Wang;Manoj S Nair;Lihong Liu;Sho Iketani;Sho Iketani

Frequent Co-Authors

John R. Mascola
John R. Mascola ModeX Therapeutics
Tongqing Zhou
Tongqing Zhou National Institutes of Health
Baoshan Zhang
Baoshan Zhang National Institute of Allergy and Infectious Diseases
Gwo-Yu Chuang
Gwo-Yu Chuang Moderna Therapeutics (United States)
Ivelin S. Georgiev
Ivelin S. Georgiev Vanderbilt University Medical Center
Lawrence Shapiro
Lawrence Shapiro Columbia University
Yongping Yang
Yongping Yang National Institutes of Health
Richard T. Wyatt
Richard T. Wyatt Scripps Research Institute
Marie Pancera
Marie Pancera Fred Hutchinson Cancer Research Center
Joseph Sodroski
Joseph Sodroski Harvard Medical School

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in expanding their expertise in Immunology, pursuing advanced nursing roles can be a strategic career move. Programs such as acnp programs offer specialized training for those aiming to work in acute care settings, combining immunological knowledge with practical patient care skills.

Accelerated nursing pathways provide efficient routes to certification for those looking to enter the healthcare field rapidly. The nurse practitioner accelerated program options are ideal for students with prior degrees who want to fast-track their entry into advanced nursing roles that often involve immunology-related specialties.

For individuals without a nursing background, the availability of online adn programs for non nurses opens doors to foundational nursing education, setting the stage for future specialization in fields such as immunology or infectious disease.

Additionally, accelerated nursing programs are designed to help students efficiently transition into nursing careers, which can lead to diverse opportunities in immunology-related research and clinical practice. Exploring these pathways can significantly enhance one’s ability to contribute to immune health and disease management.

Best Scientists Citing Peter D. Kwong

Trending Scientists

Recently Published Articles